DGX

Quest Diagnostics
D

DGX

Arincen63/100B
255.59
USD
0.87
(0.34%)
Pre Open
Fair value202.30Plus+26%77Price 255.59264
Q4 FY2026 · Earnings report
EPS estimate 2.68Revenue estimate 3.04B
OverviewFinancialsForecastEarningsDividendsCompany

Quest Diagnostics market cap

Quest Diagnostics's market cap is 28.21B USD: 110,373,360 shares outstanding at today's price of 255.59.

Today
28.21B
Average, 5 years
18.01B
Low, 5 years
13.51B
High, 5 years
28.21B

Market cap = price × shares outstanding = 255.59 × 110.37M = 28.21B

Each day's closing price times the shares outstanding in the last 10-Q or 10-K filed by then (the quarter's basic share count, adjusted for splits); from the latest count on, the shares outstanding now.

Market cap by year and by quarter

Fiscal yearPeriod endingMarket cap
Today28.21B
FY202531 Dec 202519.26B
FY202431 Dec 202416.75B
FY202331 Dec 202315.44B
FY202231 Dec 202218.15B
FY202131 Dec 202121.63B
FY202031 Dec 202015.97B
FY201931 Dec 201914.31B
FY201831 Dec 201811.32B
FY201731 Dec 201713.49B
FY201631 Dec 201612.87B
FY201531 Dec 201510.24B
FY201431 Dec 20149.72B
FY201331 Dec 20138.14B
FY201231 Dec 20129.24B
FY201131 Dec 20119.21B
FY201031 Dec 20109.48B
FY200931 Dec 200911.22B
FY200831 Dec 200810.09B
FY200731 Dec 200710.22B
FY200631 Dec 200610.44B
FY200531 Dec 200510.39B
FY200431 Dec 20049.74B
FY200331 Dec 20037.57B
FY200231 Dec 20025.49B
FY200131 Dec 20016.69B
FY200031 Dec 20006.36B
FY199931 Dec 19991.04B
FY199831 Dec 1998532.02M
FY199731 Dec 1997488.86M
FY199631 Dec 1996443.97M

See also:P/E ratio,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Quest Diagnostics's market cap

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.